BRIEF-Catalyst Pharmaceuticals announces positive top-line PHASE 3 data from Firdapse clinical trial
September 29, 2014 at 16:23 PM EDT
* Announces positive top-line PHASE 3 data from Firdapse clinical trial in patients with lambert-eaton myasthenic syndrome